KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Current Deferred Revenue (2023 - 2025)

Historic Current Deferred Revenue for Petmed Express (PETS) over the last 3 years, with Q4 2025 value amounting to $832000.0.

  • Petmed Express' Current Deferred Revenue fell 3066.67% to $832000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $832000.0, marking a year-over-year decrease of 3066.67%. This contributed to the annual value of $2.1 million for FY2025, which is 1932.39% down from last year.
  • Latest data reveals that Petmed Express reported Current Deferred Revenue of $832000.0 as of Q4 2025, which was down 3066.67% from $1.0 million recorded in Q3 2025.
  • Petmed Express' 5-year Current Deferred Revenue high stood at $3.6 million for Q3 2023, and its period low was $832000.0 during Q4 2025.
  • Moreover, its 3-year median value for Current Deferred Revenue was $2.1 million (2025), whereas its average is $2.1 million.
  • As far as peak fluctuations go, Petmed Express' Current Deferred Revenue crashed by 6129.03% in 2024, and later plummeted by 1932.39% in 2025.
  • Petmed Express' Current Deferred Revenue (Quarter) stood at $3.1 million in 2023, then tumbled by 61.29% to $1.2 million in 2024, then tumbled by 30.67% to $832000.0 in 2025.
  • Its Current Deferred Revenue stands at $832000.0 for Q4 2025, versus $1.0 million for Q3 2025 and $1.1 million for Q2 2025.